Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3.

Bioorg Med Chem Lett

Department of Medicinal Chemistry, AstraZeneca R&D Södertälje, S-151 85, Södertälje, Sweden.

Published: March 2006

The design and synthesis of a new series of c-Jun N-terminal kinase-3 (JNK3) inhibitors with selectivity against JNK1 are reported. The novel series of substituted 2'-anilino-4,4'-bipyridines were designed based on a combination of hits from high throughput screening and X-ray crystal structure information of compounds crystallized into the JNK3 ATP binding active site.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.11.039DOI Listing

Publication Analysis

Top Keywords

design synthesis
8
c-jun n-terminal
8
n-terminal kinase-3
8
synthesis 2'-anilino-44'-bipyridines
4
2'-anilino-44'-bipyridines selective
4
selective inhibitors
4
inhibitors c-jun
4
kinase-3 design
4
synthesis series
4
series c-jun
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!